Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion type Assertion NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_head.
- NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion wasGeneratedBy ECO_0000203 NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion wasDerivedFrom befree-20150227 NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion SIO_000772 20447716 NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion evidence source_evidence_literature NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.
- NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_assertion description "[Sorafenib induces the suppression of collagen accumulation and HSC growth warranting the use of sorafenib as a potential therapeutic agent in the treatment of liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414496.RA4Exfg4r_wJc6BiSzIxvHue-Wfcy3CGoc3Q_5_Gv023o130_provenance.